History

Mission & Vision

Future Plans

 

API International

 

Marksans Pharma Ltd is a leading manufacturer of Active Pharmaceutical Ingredients (API) addressing the antibiotic and anti-ulcerant and other important therapeutic segments in India. Commenced on 1992 serving industry since one and half decades with excellent quality, complying with required international standards at competitive rates.

It has embarked on ambitious expansion projects to scale up its existing capacity, to enter new therapeutic segments covering high growth lifestyle-related diseases and to be present over the entire value chain of the drug discovery and development process.

Marksans Pharma Ltd have been supplying & exporting regularly to all major consumers like Ranbaxy, Cipla, Zydus Cadila, Cadila Pharmaceuticals, Alkem, Bayer India, Alembic Ltd, Torrent Pharma and Blue Cross. Marksans Pharma Ltd. exports about 40% of it produce to various countries like Japan, Latin America, Bangladesh, Spain, Egypt, Jordan, Iran, Mexico, Germany and Africa.

 

Products

 

  • Ciprofloxacin HCL IP/USP/BP/EP
  • Enrofloxacin Base
  • Ranitidine HCL IP/USP/BP/EP
  • NMSM (Intermediate of Ranitidine HCL)
  • F.Q.Acid (Intermediate of Ciprofloxacin)
  • Ciprofloxacin Acrylate
  • Metformin Hydrochloride
  • Tinidazole
  • Trimethoprim
  • Dicyclomine Hydrochloride
  • Methyldopa
  • Glucosamine Hydrochloride
  • Glucosamine Sulphate
  • Glucosamine Sulphate Potassium Chloride
  • Glucosamine Sulphate Sodium Chloride
  • Erythromycin Stearate
  • Erythomycin Estolate
  • Roxythromycin
  • Atenolol
  • Mefenamic Acid
  • 3,4,5 Trimethoxybenzaldehyde
  • Chitin
  • N-Acetyl Glucosamine

Products in pipeline
 
  • Cardiovascular
    Ramipril
    Carvedilol
    Atorvastatin
    Fenofibrate
    Losartan

  • Antidiabetics
    Pioglitazone
    Rosiglitazone
    Glimepiride

  • CNS
    Citalopram
    Venlafaxine
    Risperidone
    Mirtazapine
Copyright 2006 (c), Marksans Pharma Ltd.,All rights reserved